Prevalence Survey of Healthcare Associated Infections (HAIs) and Antimicrobial Use in U.S. Acute Care Hospitals

ICR 202207-0920-011

OMB: 0920-0852

Federal Form Document

Forms and Documents
Document
Name
Status
Form
Modified
Form
Modified
Supplementary Document
2022-08-02
Supplementary Document
2022-08-02
Supplementary Document
2022-08-02
Supplementary Document
2022-08-02
Supplementary Document
2022-08-02
Supplementary Document
2022-08-02
Supplementary Document
2022-08-02
Supplementary Document
2022-08-02
Justification for No Material/Nonsubstantive Change
2022-08-02
Supplementary Document
2021-12-27
Supplementary Document
2021-12-23
Supplementary Document
2021-12-23
Supplementary Document
2021-12-23
Supplementary Document
2021-12-23
Supplementary Document
2021-12-23
Supplementary Document
2021-12-23
Supplementary Document
2021-12-23
Supplementary Document
2021-12-23
Supplementary Document
2021-12-23
Supplementary Document
2021-12-23
Supplementary Document
2021-12-23
Supplementary Document
2021-12-23
Supplementary Document
2021-12-23
Supplementary Document
2021-12-23
Supplementary Document
2021-12-23
Supporting Statement B
2021-12-23
Supporting Statement A
2021-12-23
IC Document Collections
IC ID
Document
Title
Status
192452 Modified
192451 Modified
ICR Details
0920-0852 202207-0920-011
Received in OIRA 202112-0920-006
HHS/CDC 0920-0852
Prevalence Survey of Healthcare Associated Infections (HAIs) and Antimicrobial Use in U.S. Acute Care Hospitals
No material or nonsubstantive change to a currently approved collection   No
Regular 08/03/2022
  Requested Previously Approved
03/31/2025 03/31/2025
6,400 6,400
1,860 1,860
65,770 65,770

Preventing healthcare-associated infections (HAIs) and improving antimicrobial use (AU) are CDC and national priorities. An extension of the prevalence survey’s existing OMB approval is sought to allow a repeat HAI and AU Prevalence Survey to be performed in 2020. A repeat survey will allow assessment of changes in HAI and AU prevalence, pathogen distribution, and quality of antimicrobial prescribing. These data will also allow CDC and its partners to continue to monitor HAI and AU trends, to measure progress in meeting national targets, and to further refine prevention strategies.

US Code: 42 USC 241 Name of Law: Public Health Service Act
   PL: Pub.L. 111 - 5 1 Name of Law: American Recovery and Reinvestment Act of 2009
  
None

Not associated with rulemaking

  86 FR 44723 08/03/2021
86 FR 73286 12/27/2021
Yes

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 6,400 6,400 0 0 0 0
Annual Time Burden (Hours) 1,860 1,860 0 0 0 0
Annual Cost Burden (Dollars) 65,770 65,770 0 0 0 0
No
No

$2,003,060
Yes Part B of Supporting Statement
    No
    No
No
No
Yes
No
Renita Macaluso 770 488-6458 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
08/03/2022


© 2022 OMB.report | Privacy Policy